4 weeks Avidity Biosciences’ (RNA) Buy Rating Reaffirmed at Needham & Company LLCMarketBeat
Needham & Company LLC reaffirmed a “buy” rating and issued a $60.00 price target on shares of Avidity Biosciences in a research report on Thursday.
XNeedham & Company LLC reaffirmed a “buy” rating and issued a $60.00 price target on shares of Avidity Biosciences in a research report on Thursday.
X